| Literature DB >> 3232125 |
J M Walenga1, M Petitou, M Samama, J Fareed, J Choay.
Abstract
Previous theoretical and experimental evidence led to the formulation of a specific pentasaccharide structure which represents the site in heparin for binding to antithrombin III. This pentasaccharide was subsequently synthesized. A pentasaccharide of the same structure but lacking only the sulfate group on the hydroxyl group of the middle glucosamine (position C-3) was also synthesized to test the structure - activity relationships. Previous biochemical studies showed the 3-O-desulfated pentasaccharide to have a low affinity binding to AT III and to be devoid of the high anti-factor Xa activity characteristic of the pentasaccharide. Our in vivo studies, in a venous stasis thrombosis model proved the 3-O-desulfated pentasaccharide, at equigravimetric dosages, to be devoid of the antithrombotic activity previously reported for the pentasaccharide. These studies confirm the fact that inhibition of factor Xa at a high level of activity produces an antithrombotic effect.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3232125 DOI: 10.1016/0049-3848(88)90128-4
Source DB: PubMed Journal: Thromb Res ISSN: 0049-3848 Impact factor: 3.944